Navigation Links
StoredIQ Shares Expertise at IQPC's eDiscovery Pharma, Biotech and Medical Device Conference

AUSTIN, Texas, Sept. 10 /PRNewswire/ --

WHO: Panel of leading eDiscovery experts including Dan Junk, Esq., VP of Business Development, StoredIQ

WHEN: Tuesday, September 15th

9:50 a.m. ET

WHERE: IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries

The Hub Cira Centre -- Philadelphia, PA

TOPIC: Cost-Benefit Analysis of In-house eDiscovery Tools vs. Outsourcing Help


Product liability lawsuits, patent disputes, class action claims, and regulatory investigations continue to challenge healthcare companies. IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries, focuses on eDiscovery and retention specifically for the highly regulated and litigious drug and medical device markets.

Addressing the cost and benefits of bringing eDiscovery in-house, StoredIQ's Vice President of Business Development, will take part in a panel discussion which includes Dr. Ellen Voorhees, TREC Project Manager from the National Institute of Standards and Technology and Huong Nyugen, Director of Intellectual Property from Impax Laboratories. Panel discussions will center on:

  • Examining how the eDiscovery tools and trends have changed and how they are evolving
  • Persuading the executive management the importance of eDiscovery readiness via a comprehensive cost-benefit analysis
  • Discussing impact of technology that is evolving faster than the laws and identifying areas of increasing importance when vetting eDiscovery technologies
  • Matching the right system with the right internal team

HOW: For more information about the conference and to register, visit:

About StoredIQ

StoredIQ is a leading provider of enterprise-class Intelligent Information Management solutions, enabling organizations to gain visibility and control over business-critical information to help meet their compliance, governance and legal discovery requirements. The company provides a range of integrated solutions for fast response to litigation and investigations, for proactive "litigation readiness," and for information protection and risk management, as well as storage management. Industry-leading companies rely on StoredIQ's award-winning technology to streamline their information management and eDiscovery processes to reduce the risk, complexity and cost of litigation. For more information, visit

StoredIQ is a trademark of StoredIQ, Inc. All other trademarks may or may not be trademarks or registered trademarks of their respective owners.

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
3. Neuralstem Shares Accepted for Trading on Amex(R)
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
6. Essilor Cancels 700,000 Shares
7. Helix BioPharma announces $16.9 million private placement of common shares
8. Helix BioPharma closes $16.9 million private placement of common shares
9. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
10. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
11. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
Post Your Comments:
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):